Itafos Inc. (CVE:IFOS – Get Free Report) was down 23.4% on Thursday. The company traded as low as C$1.60 and last traded at C$1.64. 663,295 shares traded hands during mid-day trading, an increase of 349% from the average session volume of 147,860 shares. The stock had previously closed at C$2.14.
Wall Street Analyst Weigh In
Separately, Raymond James Financial cut their target price on Itafos from C$4.50 to C$3.75 and set an “outperform” rating on the stock in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Buy rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of C$3.75.
Check Out Our Latest Research Report on Itafos
Itafos Stock Down 22.9%
The company has a current ratio of 2.12, a quick ratio of 0.72 and a debt-to-equity ratio of 19.32. The firm has a market cap of C$321.39 million, a P/E ratio of 6.35 and a beta of -0.05. The company’s 50 day simple moving average is C$2.24 and its 200-day simple moving average is C$2.75.
Itafos Company Profile
Itafos Inc operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid. It also owns interests in the Farim, a phosphate mine project situated in Farim, Guinea-Bissau; Araxá, a rare earth element and niobium mine and extraction plant project that is situated in Minas Gerais, Brazil; Arraias, an integrated phosphate fertilizer project located in Tocantins, Brazil; and Santana, an integrated phosphate mine and fertilizer plant project located in Pará, Brazil.
Featured Articles
- Five stocks we like better than Itafos
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Itafos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itafos and related companies with MarketBeat.com's FREE daily email newsletter.
